| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,009 | 0,017 | 21:17 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.10. | Preveceutical Medical Inc: Preveceutical closes first tranche of financing | 3 | Stockwatch | ||
| 22.10. | PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement | 476 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased announce that, further... ► Artikel lesen | |
| 29.09. | Preveceutical Medical Inc: Preveceutical Medical arranges $600,000 financing | 5 | Stockwatch | ||
| 28.09. | PreveCeutical launches private placement to raise up to $600,000 | 1 | Seeking Alpha | ||
| 28.09. | PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement | 392 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered... ► Artikel lesen | |
| PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln | |||||
| 04.08. | PreveCeutical Medical Inc.: PreveCeutical Closes Fourth Tranche of Non-Brokered Private Placement | 668 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 28.07. | Preveceutical Medical Inc: Preveceutical Medical closes third tranche of financing | 3 | Stockwatch | ||
| 27.07. | PreveCeutical Medical Inc.: PreveCeutical Closes Third Tranche of Non-Brokered Private Placement | 486 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 13.06. | Preveceutical Medical Inc: Preveceutical closes $245K second tranche of placement | 4 | Stockwatch | ||
| 12.06. | PreveCeutical Medical Inc.: PreveCeutical Closes Second Tranche of Non-Brokered Private Placement | 978 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen | |
| 08.06. | Preveceutical Medical Inc: Preveceutical investment BioGene names Howton director | 6 | Stockwatch | ||
| 08.06. | PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors | 742 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 8, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical"), a health sciences company that develops innovative... ► Artikel lesen | |
| 20.05. | PreveCeutical Medical Inc.: PreveCeutical Announces Extension of Non-Brokered Private Placement | 811 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that,... ► Artikel lesen | |
| 12.05. | PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement | 634 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that,... ► Artikel lesen | |
| 22.04. | PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement | 597 | Newsfile | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE:... ► Artikel lesen | |
| 01.04. | PreveCeutical Medical Inc.: PreveCeutical Adopts Semi-Annual Financial Reporting | 705 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected... ► Artikel lesen | |
| 30.03. | PreveCeutical Medical Inc.: PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director | 588 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or the "Company"), a health sciences company that... ► Artikel lesen | |
| 25.02. | PreveCeutical Medical Inc.: PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology | 756 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 25, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that... ► Artikel lesen | |
| 09.02. | PreveCeutical Medical Inc.: PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents | 508 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it... ► Artikel lesen | |
| 04.12.25 | PreveCeutical Medical Inc.: PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology | 565 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 52,48 | +1,18 % | ROUNDUP: Fresenius baut Geschäft mit Nachahmer-Medikamenten aus | BAD HOMBURG (dpa-AFX) - Der Gesundheitskonzern Fresenius baut mit einer Entwicklungsvereinbarung mit dem chinesischen Auftragsforscher und -fertiger WuXi Biologics seine Pipeline von Nachahmermedikamenten... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,230 | -0,21 % | FMC grenzt Ergebnis-Ausblick für Gesamtjahr 2026 ein | DJ FMC grenzt Ergebnis-Ausblick für Gesamtjahr 2026 ein
Von Britta Becks
DOW JONES--Der Dialysedienstleister Fresenius Medical Care (FMC) hat seinen Ergebnis-Ausblick für das laufende Jahr... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,660 | +0,22 % | EQS-AFR: Siemens Healthineers AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Siemens Healthineers AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Siemens Healthineers AG: Vorabbekanntmachung... ► Artikel lesen | |
| INTUITIVE SURGICAL | 405,40 | -2,97 % | ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising? | ||
| DRAEGERWERK | 103,20 | -1,53 % | Carl Zeiss Meditec, Drägerwerk, Sartorius: Wo Analysten das meiste Potenzial sehen | ||
| MEDTRONIC | 91,90 | -1,67 % | Medtronic: She Spent Years Improving Stroke Care, Then It Helped Save Her Sister | NORTHAMPTON, MA / ACCESS Newswire / November 3, 2026 / MedtronicHeather Vannes spent years shaving minutes off stroke care. When her sister collapsed on an ordinary afternoon, every one of those minutes... ► Artikel lesen | |
| THERMO FISHER | 623,00 | +3,21 % | Thermo Fisher Scientific: 5-Milliarden-Rückkauf, aber die Aktie fällt - der Haken | ||
| TELADOC HEALTH | 7,950 | -5,36 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | ||
| SERNOVA BIOTHERAPEUTICS | 0,067 | -5,35 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| FAMICORD | 2,570 | +0,78 % | EQS-Adhoc: FamiCord AG: FamiCord beschließt Bezugspreis und Anzahl neuer Aktien für beabsichtigte Bezugsrechtskapitalerhöhung | EQS-Ad-hoc: FamiCord AG / Schlagwort(e): Kapitalmaßnahmen / Kapitalerhöhung
FamiCord AG: FamiCord beschließt Bezugspreis und Anzahl neuer Aktien für beabsichtigte Bezugsrechtskapitalerhöhung... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,625 | -45,90 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| BRIGHTSPRING HEALTH SERVICES | 67,24 | +2,10 % | Guggenheim raises BrightSpring Health stock price target on growth | ||
| BILLIONTOONE | 109,60 | -2,48 % | BTIG reiterates Buy on BillionToOne stock, keeps $130 target | ||
| PRIVIA HEALTH GROUP | 24,290 | +1,46 % | Privia Health Group, Inc. - 10-Q, Quarterly Report | ||
| LIFESTANCE HEALTH GROUP | 13,830 | +2,98 % | BMO raises Lifestance Health stock price target on strong results |